Biofarm S.A. (BVB:BIO)

Market Cap	1.05B +47.4%
Revenue (ttm)	318.89M +12.9%
Net Income	88.21M +9.8%
EPS	0.08 +9.4%
Shares Out	985.37M
PE Ratio	13.16
Forward PE	n/a
Dividend	0.03 (2.90%)
Ex-Dividend Date	Aug 18, 2025

Volume	123,477
Average Volume	324,432
Open	1.115
Previous Close	1.115
Day's Range	1.060 - 1.115
52-Week Range	0.620 - 1.200
Beta	0.24
RSI	65.43
Earnings Date	Feb 27, 2026

About Biofarm

Biofarm S.A. manufactures and sells medicines in Romania. The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and antipyretics, dermatology, digestive and metabolic, endocrine, genitourinary, multivitamins, ophthalmology, musculoskeletal, respiratory and ENT, and neurology. It provides prescription and non-prescription medicines, food supplements, medical devices, cosmetics, and other products. The company also exports its products in Azerbaijan, Albania, Georg...

• Industry: Pharmaceutical Preparations
• Founded: 1921
• Employees: 367
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: BIO

Financial Performance

In 2024, Biofarm's revenue was 286.77 million, an increase of 2.31% compared to the previous year's 280.29 million. Earnings were 74.40 million, a decrease of -3.40%.